loadpatents
name:-0.021690130233765
name:-0.029139995574951
name:-0.028034925460815
SHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO., LTD. Patent Filings

SHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO., LTD.

Patent Applications and Registrations

Patent applications and USPTO patent grants for SHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO., LTD..The latest application filed is for "btk inhibitors, pharmaceutically acceptable salts, polymorphs and application thereof".

Company Profile
33.40.22
  • SHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO., LTD. - Shanghai CN
  • SHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO., LTD. - N/A
  • SHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO., LTD. - KR KR
  • SHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO., LTD - Shanghai CN
  • Shanghai Haiyan Pharmaceutical Technology Co., Ltd. - Pudong New Area Shanghai CN
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Btk Inhibitors, Pharmaceutically Acceptable Salts, Polymorphs And Application Thereof
App 20210395247 - JIANG; Taotao ;   et al.
2021-12-23
Substituted Phenylpropenyl Pyridine Derivatives, Their Preparation And Pharmaceutical Applications
App 20210386721 - ZHU; Weixing ;   et al.
2021-12-16
Aniline-substituted 1,2-dihydropyrrol[3,4-C]pyridin/pyrimidin-3-one derivative and use thereof
Grant 11,174,254 - Guo , et al. November 16, 2
2021-11-16
Pyridylamino substituted heterotricyclic compounds, and preparation method and pharmaceutical use thereof
Grant 11,168,088 - Liu , et al. November 9, 2
2021-11-09
4,6,7-trisubstituted 1,2-dihydropyrrolo[3,4-c]pyridin/pyrimidin-3-one derivatives and uses thereof
Grant 11,155,546 - Guo , et al. October 26, 2
2021-10-26
4,5,6-trisubstituted indazole derivatives, and preparation method and pharmaceutical use thereof
Grant 11,104,664 - Peng , et al. August 31, 2
2021-08-31
Cdk4/6 Inhibitor And Pharmaceutically Acceptable Salt And Polymorph Thereof And Use Thereof
App 20210214358 - JIANG; Taotao ;   et al.
2021-07-15
Ezh2 Inhibitor And Pharmaceutically Acceptable Salts And Polymorphic Substances Thereof, And Application Of Ezh2 Inhibitor
App 20210188813 - JIANG; Taotao ;   et al.
2021-06-24
Pharmaceutically Acceptable Salts Of Benzodicycloalkane Derivative, Polymorphic Substance Thereof, And Application Thereof
App 20210087156 - DAN; Zhaoling ;   et al.
2021-03-25
Sodium ion channel inhibitors and pharmaceutically acceptable salts and polymorphs thereof and uses thereof
Grant 10,947,202 - Wang , et al. March 16, 2
2021-03-16
Crystal form of orexin receptor antagonist compound, and preparation method and application thereof
Grant 10,912,775 - Wu , et al. February 9, 2
2021-02-09
Crystal form of orexin receptor antagonist compound, and preparation method and application thereof
Grant 10,898,486 - Wu , et al. January 26, 2
2021-01-26
Crystal form of orexin receptor antagonist compound, and preparation method and application thereof
Grant 10,874,674 - Wu , et al. December 29, 2
2020-12-29
N-sulfonyl benzamides as voltage-gated sodium channel inhibitors
Grant 10,815,197 - Lan , et al. October 27, 2
2020-10-27
Sulfuryl-substituted benzoheterocyclic derivative, preparation method and medical use thereof
Grant 10,793,549 - Jin , et al. October 6, 2
2020-10-06
Crystal Form Of Orexin Receptor Antagonist Compound, And Preparation Method And Application Thereof
App 20200261452A1 -
2020-08-20
4, 5, 6-tri-substituted Indazoles Derivatives, Preparation Thereof And Use Thereof In Medicines
App 20200262812A1 -
2020-08-20
1,5,7-trisubstituted Isoquinoline Derivatives, Preparation Thereof, And Use Thereof In Medicines
App 20200262813A1 -
2020-08-20
Crystal Form Of Orexin Receptor Antagonist Compound, And Preparation Method And Application Thereof
App 20200261453A1 -
2020-08-20
Crystal Form Of Orexin Receptor Antagonist Compound, And Preparation Method And Application Thereof
App 20200253972 - Kind Code
2020-08-13
4,6,7-trisubstituted 1,2-dihydropyrrolo[3,4-c]pyridin/pyrimidin-3-one Derivatives And Uses Thereof
App 20200223846A1 -
2020-07-16
Crystal form of orexin receptor antagonist compound, and preparation method and application thereof
Grant 10,668,066 - Wu , et al.
2020-06-02
Benzobicycloalkane derivatives, their preparation and pharmaceutical use thereof
Grant 10,577,346 - Zhou , et al.
2020-03-03
EGFR inhibitor and pharmaceutically acceptable salt and polymorph thereof, and use thereof
Grant 10,561,646 - Lan , et al. Feb
2020-02-18
Aniline-substituted 1,2-dihydropyrrol[3,4-c]pyridin/pyrimidin-3-one Derivative And Use Thereof
App 20200048248 - GUO; Shuchun ;   et al.
2020-02-13
Sodium Ion Channel Inhibitors And Pharmaceutically Acceptable Salts And Polymorphs Thereof And Uses Thereof
App 20200048209 - WANG; Zheng ;   et al.
2020-02-13
Pyridylamino Substituted Heterotricyclic Compounds, And Preparation Method And Pharmaceutical Use Thereof
App 20200039983 - LIU; Yang ;   et al.
2020-02-06
PI3K inhibitor, and pharmaceutically acceptable salt, polycrystalline form, and application thereof
Grant 10,544,137 - Jiang , et al. Ja
2020-01-28
2,4-disubstituted phenylene-1,5-diamine derivatives and applications thereof, and pharmaceutical compositions and pharmaceutically acceptable compositions prepared therefrom
Grant 10,435,400 - Lan , et al. O
2019-10-08
Sulfonyl-substituted Benzoheterocyclic Derivative, Preparation Method And Medical Use Thereof
App 20190300506 - JIN; Yunzhou ;   et al.
2019-10-03
Benzodicycloalkane Derivative, Preparation Method And Use Thereof
App 20190161468 - ZHOU; Fusheng ;   et al.
2019-05-30
Pi3k Inhibitor, And Pharmaceutically Acceptable Salt, Polycrystalline Form, And Application Thereof
App 20190152964 - JIANG; Taotao ;   et al.
2019-05-23
2-morpholin-4,6-disubstituted pyrimidine derivative, and preparation method and pharmaceutical use thereof
Grant 10,227,324 - Shen , et al.
2019-03-12
N-sulfonyl Benzamide Derivative With Heterocyclic Substituent, Preparation Method Therefor And Pharmaceutical Application Thereof
App 20190023654 - LAN; Jiong ;   et al.
2019-01-24
Piperidine derivatives as orexin receptor antagonist
Grant 10,100,047 - He , et al. October 16, 2
2018-10-16
Azabicyclo derivatives, process for preparation thereof and medical use thereof
Grant 10,085,983 - Jin , et al. October 2, 2
2018-10-02
Crystal Form Of Orexin Receptor Antagonist Compound, And Preparation Method And Application Thereof
App 20180235965 - WU; Songliang ;   et al.
2018-08-23
2,4-disubstituted 7H-pyrrolo[2,3-d]pyrimidine derivative, preparation method and medicinal use thereof
Grant 9,890,168 - Lan , et al. February 13, 2
2018-02-13
2,3,4,6-tetra-substituted benzene-1,5-diamine derivatives, preparation method therefor and medicinal use thereof
Grant 9,879,008 - Lan , et al. January 30, 2
2018-01-30
2-morpholin-4,6-disubstituted Pyrimidine Derivative, And Preparation Method And Pharmaceutical Use Thereof
App 20170349568 - SHEN; Sida ;   et al.
2017-12-07
Azabicyclo Derivatives, Process For Preparation Therof And Medical Use Thereof
App 20170296537 - JIN; Yunzhou ;   et al.
2017-10-19
2,4-disubstituted 7h-pyrrolo[2,3-d]pyrimidine Derivative, Preparation Method And Medicinal Use Thereof
App 20170233395 - LAN; Jiong ;   et al.
2017-08-17
Piperidine Derivatives As Orexin Receptor Antagonist
App 20170233385 - HE; Haiying ;   et al.
2017-08-17
2,3,4,6-tetra-substituted Benzene-1,5-diamine Derivatives, Preparation Method Therefor And Medicinal Use Thereof
App 20170057957 - LAN; Jiong ;   et al.
2017-03-02
2,4-disubstituted Phenylene-1,5-diamine Derivatives And Applications Thereof, And Pharmaceutical Compositions And Pharmaceutically Acceptable Compositions Prepared Therefrom
App 20170008889 - LAN; Jiong ;   et al.
2017-01-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed